CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel
published in: Breast Cancer Research and Treatment
date of publication: 2012-04-18
language: English
main subject: patient, breast cancer
Cites articles 51
Date
Title
Article - wd:Q37055326